140 related articles for article (PubMed ID: 32787764)
1. The MMP-2/TIMP-2 System in Alzheimer Disease.
Wang H; Huang L; Wu L; Lan J; Feng X; Li P; Peng Y
CNS Neurol Disord Drug Targets; 2020; 19(6):402-416. PubMed ID: 32787764
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
Ridnour LA; Dhanapal S; Hoos M; Wilson J; Lee J; Cheng RY; Brueggemann EE; Hines HB; Wilcock DM; Vitek MP; Wink DA; Colton CA
J Neurochem; 2012 Dec; 123(5):736-49. PubMed ID: 23016931
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
4. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.
Liao MC; Van Nostrand WE
Biochemistry; 2010 Feb; 49(6):1127-36. PubMed ID: 20050683
[TBL] [Abstract][Full Text] [Related]
5. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.
Krizanac-Bengez L; Hossain M; Fazio V; Mayberg M; Janigro D
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C740-9. PubMed ID: 16707552
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.
Tuna G; Yener GG; Oktay G; İşlekel GH; Kİrkalİ FG
J Alzheimers Dis; 2018; 66(3):1265-1273. PubMed ID: 30412498
[TBL] [Abstract][Full Text] [Related]
7. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
8. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
10. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms.
Sinno M; Biagioni S; Ajmone-Cat MA; Pafumi I; Caramanica P; Medda V; Tonti G; Minghetti L; Mannello F; Cacci E
Stem Cells Dev; 2013 Feb; 22(3):345-58. PubMed ID: 23098139
[TBL] [Abstract][Full Text] [Related]
12. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of gelatinase A and B and TIMP-1 and -2 by TNFalpha and HIV virions in astrocytes.
Lévêque T; Le Pavec G; Boutet A; Tardieu M; Dormont D; Gras G
Microbes Infect; 2004 Feb; 6(2):157-63. PubMed ID: 14998513
[TBL] [Abstract][Full Text] [Related]
14. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease.
Lorenzl S; Albers DS; Narr S; Chirichigno J; Beal MF
Exp Neurol; 2002 Nov; 178(1):13-20. PubMed ID: 12460604
[TBL] [Abstract][Full Text] [Related]
15. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
Leśniak-Walentyn A; Hrabia A
Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase imbalance in inguinal hernia formation.
Antoniou GA; Tentes IK; Antoniou SA; Simopoulos C; Lazarides MK
J Invest Surg; 2011; 24(4):145-50. PubMed ID: 21675849
[TBL] [Abstract][Full Text] [Related]
19. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
Bastos MF; Tucci MA; de Siqueira A; de Faveri M; Figueiredo LC; Vallim PC; Duarte PM
J Periodontal Res; 2017 Apr; 52(2):292-299. PubMed ID: 27363729
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
